Workboat Indexes
Headline News about Beam Therapeutics Inc
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://g.foolcdn.com/editorial/images/735895/dna-on-monitor-scientists.jpg)
![](https://g.foolcdn.com/editorial/images/733047/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://g.foolcdn.com/editorial/images/731107/dna-on-monitor-scientists.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1789.jpeg?width=1200&height=800&fit=crop)
Beam Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/03/cathie-wood-stocks-1600.png)
![](/next-assets/images/schema-image-default.png)
Where Beam Therapeutics Stands With Analysts
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Beam Therapeutics Stands With Analysts
March 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Beam Therapeutics
February 01, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/730177/dna-on-monitor-scientists.jpg)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Tesla_Photo_by_Roschetzky_Photography_on_Shutterstock_4.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/01/stocks-to-watch-chart-businessman-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_02.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/02/dna-helix.png)
![](https://g.foolcdn.com/editorial/images/723147/dna-on-monitor-scientists.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min-1.jpg)
![](https://g.foolcdn.com/editorial/images/721399/dna-genetic-sequencing-biotech-1.jpg)
![](https://g.foolcdn.com/editorial/images/718384/scientists-in-a-lab-smiling.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2531.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://g.foolcdn.com/editorial/images/717988/gettyimages-1408041303.jpg)
5 Top Stocks for February
January 29, 2023
Via The Motley Fool
![](https://g.foolcdn.com/editorial/images/718114/dna-on-monitor-scientists.jpg)
![](https://g.foolcdn.com/editorial/images/716587/bull-silhouette.jpg)
![](https://g.foolcdn.com/editorial/images/715659/3-generations-of-hispanic-women.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.